- Report
- May 2021
- 250 Pages
Global
From €8231EUR$8,950USD£6,963GBP
- Report
- February 2024
- 360 Pages
Global
From €7312EUR$7,950USD£6,185GBP
- Report
- May 2025
- 50 Pages
Global
From €2437EUR$2,650USD£2,062GBP
Tafluprost is a prostaglandin analog used to treat glaucoma and ocular hypertension. It is a type of optical disorder drug, which works by reducing intraocular pressure in the eye. It is administered as an eye drop and is available in both generic and branded forms. Tafluprost is a relatively new drug, having been approved by the US Food and Drug Administration in 2013.
Tafluprost is used to treat open-angle glaucoma and ocular hypertension, both of which are caused by increased intraocular pressure in the eye. It works by increasing the outflow of aqueous humor, which helps to reduce the pressure in the eye. It is generally well-tolerated and has few side effects.
The tafluprost market is a growing one, with many companies offering branded and generic versions of the drug. Some of the companies in the market include Allergan, Pfizer, Sun Pharmaceuticals, and Mylan. Show Less Read more